Arcturus Therapeutics Holdings 10K Form

Sell

21

ARCT
Arcturus Therapeutics Holdings

Last Price:

$12.88

Seasonality Move:

23.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-10	10Q	ARCT/Arcturus Therapeutics Holdings Quarterly
2020-05-08	10Q	ARCT/Arcturus Therapeutics Holdings Quarterly
2020-03-16	10K	ARCT/Arcturus Therapeutics Holdings Annual
2019-11-08	10Q	ARCT/Arcturus Therapeutics Holdings Quarterly
2019-08-14	10Q	ARCT/Arcturus Therapeutics Holdings Quarterly

Receive ARCT News And Ratings

See the #1 stock for the next 7 days that we like better than ARCT

ARCT Financial Statistics

Sales & Book Value

Annual Sales:	$138.4M
Cash Flow:	$-284K
Price / Cash Flow:	76.35
Annual Sales:	$8.93
Price / Book:	1.45

Profitability

EPS (TTM):	-3.01000
Net Income (TTM):	$-80.9M
Gross Margin:	$0
Return on Equity:	-31.04%
Return on Assets:	-20.74%

Arcturus Therapeutics Holdings Earnings Forecast

Key Arcturus Therapeutics Holdings Financial Ratios

The Selling, General & Administrative Expenses for ARCT have been equal to 38.17% of Gross Profit Margin.
The Research & Development expenses have been 141.02% of Revenue.
The Net Earning history of ARCT is -58.49% of Total Revenues.
Per Share Earnings over the last 14 years have been positive in 6 years.

Arcturus Therapeutics Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	ARCT
CUSIP:	M1492T
Website:	arcturusrx.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	4.67
Quick Ratio:	3.68

Price-to-Earnings

Trailing P/E Ratio:	90.09
Forward P/E Ratio:	20.96

ARCT Technical Analysis vs Fundamental Analysis

Sell

21

Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy or a Sell?

Arcturus Therapeutics Holdings stock is rated a Sell

The current Arcturus Therapeutics Holdings [ARCT] share price is $12.88. The Score for ARCT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.